Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | |
|---|---|---|---|---|---|
| Net Income | -407.41% | 50.32% | 31.77% | -402.03% | 189.27% |
| Total Depreciation and Amortization | 3.31% | 0.00% | 0.00% | 15,000.00% | 0.00% |
| Total Amortization of Deferred Charges | 125.98% | -165.11% | 115.93% | 238.26% | -188.57% |
| Total Other Non-Cash Items | 101.64% | 2,068.63% | -- | -- | -240.98% |
| Change in Net Operating Assets | 445.88% | 145.97% | -0.48% | -143.08% | 513.14% |
| Cash from Operations | 236.54% | 84.62% | 75.94% | -516.30% | 222.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 200.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.08% | -- | -- | -- | 200.00% |
| Cash from Investing | 38.08% | -- | -- | -- | 200.00% |
| Total Debt Issued | 61.99% | -33.50% | -65.83% | 135.53% | -196.06% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.25% | -213.46% | -63.64% | 190.70% | -450.37% |
| Cash from Financing | 99.45% | -62.41% | -64.73% | 138.32% | -200.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70,800.00% | -99.66% | 617.54% | -235.71% | 147.06% |
